Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Melanomas that result from mutations in the gene encoding BRAF often become resistant to BRAF inhibition (BRAFi), with multiple mechanisms contributing to resistance. While therapy-induced autophagy promotes resistance to a number of therapies, especially those that target PI3K/mTOR signaling, its role as an adaptive resistance mechanism to BRAFi is not well characterized. Using tumor biopsies from BRAF(V600E) melanoma patients treated either with BRAFi or with combined BRAF and MEK inhibition, we found that BRAFi-resistant tumors had increased levels of autophagy compared with baseline. Patients with higher levels of therapy-induced autophagy had drastically lower response rates to BRAFi and a shorter duration of progression-free survival. In BRAF(V600E) melanoma cell lines, BRAFi or BRAF/MEK inhibition induced cytoprotective autophagy, and autophagy inhibition enhanced BRAFi-induced cell death. Shortly after BRAF inhibitor treatment in melanoma cell lines, mutant BRAF bound the ER stress gatekeeper GRP78, which rapidly expanded the ER. Disassociation of GRP78 from the PKR-like ER-kinase (PERK) promoted a PERK-dependent ER stress response that subsequently activated cytoprotective autophagy. Combined BRAF and autophagy inhibition promoted tumor regression in BRAFi-resistant xenografts. These data identify a molecular pathway for drug resistance connecting BRAFi, the ER stress response, and autophagy and provide a rationale for combination approaches targeting this resistance pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Inhibition of BRAFV600E with vemurafenib induces autophagy by inhibition of the mTOR signaling pathway, and autophagy has been shown to promote survival of melanoma cells after vemurafenib81,85.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Induction of autophagy has been suggested to be a pro-survival mechanism for melanoma cells79,81,82.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 7×
“LC3 is an ubiquitin-like cytoplasmic protein that is conjugated to the surface of AVs as they are formed.”
InfluentialSelf-citationClonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Hauschild, A., Grob, J.-J., Demidov, L. V., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C. U., Miller, W. H., Kaempgen, E., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60868-x · Cited by 2,989
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response
Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P., & Ron, D. (2000) · Nature Cell Biology · doi:10.1038/35014014 · Cited by 2,860
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Self-citationPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Direct observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419 · cited 9×
“PLA was performed using Duolink In Situ fluorescence technology (Olink Bioscience).”
Influential
Cited by
Items 101–200 of 490
Autophagy—from molecular mechanisms to clinical relevance
Lippai, M., & Szatmári, Z. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9374-5 · Cited by 84
Yang, L., Guan, G., Lei, L., Lv, Q., Liu, S., Zhan, X., Jiang, Z., & Gu, X. Q. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-018-0936-8 · Cited by 83
Rangel, M., Kong, J., Bhatt, V. D., Khayati, K., & Guo, J. Y. (2021) · FEBS Journal · doi:10.1111/febs.16125 · Cited by 82
Corazao-Rozas, P., Guerreschi, P., André, F., Gabert, P.-E., Lancel, S., Dekiouk, S., Fontaine, D., Tardivel, M., Savina, A., Quesnel, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7790 · Cited by 82
Alexa‐Stratulat, T., Pešić, M., Gašparović, A. Č., Trougakos, I. P., & Riganti, C. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100643 · Cited by 81
Methods for Studying Autophagy Within the Tumor Microenvironment
Murugan, S., & Amaravadi, R. K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26666-4_9 · Cited by 80
Self-citationInsights into the role of endoplasmic reticulum stress in skin function and associated diseases
Park, K., Lee, S. E., Shin, K., & Uchida, Y. (2018) · FEBS Journal · doi:10.1111/febs.14739 · Cited by 79
Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
Garg, A. D., Maes, H., van Vliet, A. R., & Agostinis, P. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975089 · Cited by 80
Targeting Autophagy Sensitizes BRAF-Mutant Thyroid Cancer to Vemurafenib
Wang, W., Kang, H., Zhao, Y., Min, I., Wyrwas, B., Moore, M., Teng, L., Zarnegar, R., Jiang, X., & Fahey, T. J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1999 · Cited by 68
Autophagy- An emerging target for melanoma therapy
Ndoye, A., & Weeraratna, A. T. (2016) · F1000Research · doi:10.12688/f1000research.8347.1 · Cited by 78
IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling
Chen, C. Y., & Zhang, X. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1147-2 · Cited by 76
Adaptive response of resistant cancer cells to chemotherapy
Chern, Y., & Tai, I. T. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0005 · Cited by 77
Fattore, L., Ruggiero, C. F., Pisanu, M. E., Liguoro, D., Cerri, A., Costantini, S., Capone, F., Acunzo, M., Romano, G., Nigita, G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0205-5 · Cited by 75
Non-Apoptotic Cell Death Signaling Pathways in Melanoma
Hartman, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082980 · Cited by 74
Type I interferons mediate pancreatic toxicities of PERK inhibition
Yu, Q., Zhao, B., Gui, J., Katlinski, K. V., Brice, A., Gao, Y., Li, C., Kushner, J. A., Koumenis, C., Diehl, J. A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516362112 · Cited by 71
Self-citationMehnert, J. M., Mitchell, T. C., Huang, A. C. C., Alemán, T. S., Kim, B. J., Schuchter, L. M., Linette, G. P., Karakousis, G. C., Mitnick, S., Giles, L., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3382 · Cited by 70
Self-citationAutophagy dysfunction in neuropathic pain
Liu, X., Zhu, M., Ju, Y., Li, A., & Sun, X. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.03.005 · Cited by 67
Autophagy in cancer: a complex relationship
Wilde, L. R., Tanson, K., Curry, J., & Martinez‐Outschoorn, U. (2018) · Biochemical Journal · doi:10.1042/bcj20170847 · Cited by 66
Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers
Bortnik, S. B., & Gorski, S. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071496 · Cited by 66
Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors
Marchetti, P., Trinh, A., Khamari, R., & Kluza, J. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.01.018 · Cited by 66
Mahameed, M., Boukeileh, S., Obiedat, A., Darawshi, O., Dipta, P., Rimon, A., McLennan, G., Fassler, R., Reichmann, D., Karni, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15067-5 · Cited by 65
Unraveling the Molecular Nexus between GPCRs, ERS, and EMT
Kumari, N., Reabroi, S., & North, B. J. (2021) · Mediators of Inflammation · doi:10.1155/2021/6655417 · Cited by 65
Wu, N., Zheng, W., Zhou, Y., Tian, Y., Tang, M., Feng, X., Ashrafizadeh, M., Wang, Y. Z., Niu, X., Tambuwala, M. M., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102428 · Cited by 63
Melanoma and the Unfolded Protein Response
Sykes, E. K., Mactier, S., & Christopherson, R. I. (2016) · Cancers · doi:10.3390/cancers8030030 · Cited by 63
Rasche, L., Ménoret, E., Dubljevic, V., Menu, E., Vanderkerken, K., Lapa, C., Steinbrunn, T., Chatterjee, M., Knop, S. T., Düll, J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3111 · Cited by 63
Targeting Autophagy to Treat Cancer: Challenges and Opportunities
Lim, J., & Murthy, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.590344 · Cited by 63
Didier, R., Mallavialle, A., Jouira, R. B., Domdom, M. A., Tichet, M., Auberger, P., Luciano, F., Ohanna, M., Tartare‐Deckert, S., & Deckert, M. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0919 · Cited by 62
ROCK 1 is a potential combinatorial drug target for BRAF mutant melanoma
Smit, M. A., Maddalo, G., Greig, K., Raaijmakers, L. M., Possik, P. A., van Breukelen, B., Cappadona, S., Heck, A. J., Altelaar, A. M., & Peeper, D. S. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145450 · Cited by 54
Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS‐mutant melanoma
Rebecca, V. W., Alicea, G. M., Paraiso, K. H. T., Lawrence, H., Gibney, G. T., & Smalley, K. S. M. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12303 · Cited by 53
AMPK promotes tolerance to Ras pathway inhibition by activating autophagy
Sanduja, S., Feng, Y., Mathis, R. A., Sokol, E. S., Reinhardt, F., Halaban, R., & Gupta, P. B. (2016) · Oncogene · doi:10.1038/onc.2016.70 · Cited by 58
miR-346 functions as a pro-survival factor under ER stress by activating mitophagy
Guo, J., Yang, Z., Yang, X., Li, T., Liu, M., & Tang, H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.030 · Cited by 59
Autophagy in cancers including brain tumors: role of MicroRNAs
Pourhanifeh, M. H., Mahjoubin‐Tehran, M., Karimzadeh, M. R., Mirzaei, H. R., Razavi, Z. S., Sahebkar, A., Hosseini, N., Mirzaei, H., & Hamblin, M. R. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00587-w · Cited by 59
Chen, J., Zhu, Z., Pan, Q., Bai, Y., Yu, M., & Zhou, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202300235 · Cited by 58
Cell surface GRP78: a potential mechanism of therapeutic resistant tumors
Amaresan, R., & Gopal, U. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02931-9 · Cited by 58
Jegal, K. H., Park, S. M., Cho, S. S., Byun, S. H., Ku, S., Kim, S. C., Ki, S. H., & Cho, I. J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.010 · Cited by 56
Zhu, H., Cao, X., Cai, X., Tian, Y., Wang, D., Qi, J., Teng, Z., Lu, G., Ni, Q., Wang, S., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119677 · Cited by 56
Pillai, S., Mahmud, I., Mahar, R., Griffith, C., Langsen, M., Nguyen, J. V., Wojtkowiak, J. W., Swietach, P., Gatenby, R. A., Bui, M. M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110796 · Cited by 55
Two is better than one; toward a rational design of combinatorial therapy
Chen, S., & Lahav, G. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.07.020 · Cited by 55
Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt‐regulated autophagy
Zhou, L., Gao, W. Q., Wang, K., Huang, Z., Zhang, L., Zhang, Z., Zhou, J., Nice, E. C., & Huang, C. (2019) · The FASEB Journal · doi:10.1096/fj.201801983r · Cited by 55
Martin, S., Dudek-Perić, A. M., Maes, H., Garg, A. D., Gabrysiak, M., Demirsoy, S., Swinnen, J. V., & Agostinis, P. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.003 · Cited by 54
“, blockage of autophagy was shown to subvert survival and growth also in the PLX4032resistant melanoma cells [19].”
BackgroundInfluentialDenisenko, T. V., Pivnyuk, A. D., & Zhivotovsky, B. (2018) · Cancers · doi:10.3390/cancers10050148 · Cited by 54
Chloroquine Sensitizes GNAQ/11 -mutated Melanoma to MEK1/2 Inhibition
Truong, A., Yoo, J. H., Scherzer, M. T., Sanchez, J. M. S., Dale, K. J., Kinsey, C. G., Richards, J. R., Shin, D., Ghazi, P. C., Onken, M. D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1675 · Cited by 57
Targeting autophagy in skin diseases
Yu, T., Zuber, J., & Li, J. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1225-3 · Cited by 54
Autophagy and mitophagy interplay in melanoma progression
Maes, H., & Agostinis, P. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.07.003 · Cited by 53
Chen, X., Clark, J. P., Wunderlich, M., Fan, C., Davis, A. K., Chen, S., Guan, J., Mulloy, J. C., Kumar, A. R., & Zheng, Y. (2017) · Autophagy · doi:10.1080/15548627.2017.1287652 · Cited by 53
Emerging tale of UPR and cancer: an essentiality for malignancy
Hazari, Y., Bashir, A., Haq, E. U., & Fazili, K. M. (2016) · Tumor Biology · doi:10.1007/s13277-016-5343-0 · Cited by 53
Niessner, H., Sinnberg, T. W., Kosnopfel, C., Smalley, K. S. M., Beck, D., Praetorius, C., Mai, M., Beissert, S., Kulms, D., Schaller, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0098 · Cited by 52
Chang, H.-Y., Huang, T.-C., Chen, N.-N., Huang, H.-C., & Juan, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.504 · Cited by 50
Ryabaya, O. O., Inshakov, A. N., Егорова, А. В., Emelyanova, M., Nasedkina, T. V., Zasedatelev, A. S., Khochenkov, D. A., & Степанова, Е. В. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000463 · Cited by 50
Xu, J., Su, Z., Cheng, X. C., Hu, S., Wang, W., Zou, T., Zhou, X., Song, Z., Xia, Y. F., Gao, Y., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02508-y · Cited by 49
Ren, J., Hu, Z., Niu, G., Xia, J., Wang, X., Hong, R., Gu, J., Wang, D., & Ke, C. (2023) · The FASEB Journal · doi:10.1096/fj.202200400rr · Cited by 48
Design of Small Molecule Autophagy Modulators: A Promising Druggable Strategy
He, S., Li, Q., Jiang, X., Lü, X., Feng, F., Qu, W., Chen, Y., & Sun, H. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01019 · Cited by 48
Klapan, K., Simon, D., Karaulov, A. V., Gomzikova, M. O., Rizvanov, A. A., Yousefi, S., & Simon, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.844756 · Cited by 48
Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance
Cerezo, M., Lehraiki, A., Millet, A., Rouaud, F., Plaisant, M., Jaune, E., Botton, T., Ronco, C., Abbe, P., Amdouni, H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.007 · Cited by 47
Rather, R. A., Bhagat, M., & Singh, S. K. (2020) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2020.108321 · Cited by 46
Inhibition of autophagy; an opportunity for the treatment of cancer resistance
Tonkin-Reeves, A., Giuliani, C. M., & Price, J. T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1177440 · Cited by 46
Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy
Li, Y.-Y., Feun, L. G., Thongkum, A., Tu, C.-H., Chen, S.-M., Wangpaichitr, M., Wu, C., Kuo, M. T., & Savaraj, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061297 · Cited by 45
Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells
Alasiri, G. A., Jiramongkol, Y., Zona, S., Fan, L. Y.-N., Mahmud, Z., Gong, G., Lee, H. J., & Lam, E. W. ‐. (2019) · Oncogene · doi:10.1038/s41388-019-0890-7 · Cited by 45
Budina-Kolomets, A., Webster, M. R., Leu, J. I.-J., Jennis, M., Krepler, C., Guerrini, A., Kossenkov, A. V., Xu, W., Karakousis, G. C., Schuchter, L. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2137 · Cited by 45
Self-citationFatty acids in cancer chemoresistance
Qin, J., Ye, L., Wen, X., Zhang, X., Di, Y., Chen, Z., & Wang, Z. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216352 · Cited by 44
Sueda, T., Sakai, D., Kawamoto, K., Konno, M., Nishida, N., Koseki, J., Colvin, H. S., Takahashi, H., Haraguchi, N., Nishimura, J., et al. (2016) · Scientific Reports · doi:10.1038/srep18949 · Cited by 44
Lin, J., Zhang, D., Fan, Y., Chao, Y., Chang, J., Li, N., Han, L., & Han, C. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.01.023 · Cited by 44
Roles of galectin‑3 in the tumor microenvironment and tumor metabolism (Review)
Guo, Y., Shen, R., Yu, L., Zheng, X., Cui, R., Song, Y., & Wang, D. (2020) · Oncology Reports · doi:10.3892/or.2020.7777 · Cited by 44
Transmissible Endoplasmic Reticulum Stress: A Novel Perspective on Tumor Immunity
Jiang, Z., Zhang, G., Huang, L., Yuan, Y., Wu, C., & Li, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00846 · Cited by 44
Self-citationPhase i trials in melanoma: A framework to translate preclinical findings to the clinic
Kim, E., Rebecca, V. W., Smalley, K. S. M., & Anderson, A. R. A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.07.024 · Cited by 44
Vietri, M., Miranda, M. R., Amodio, G., Ciaglia, T., Bertamino, A., Campiglia, P., Remondelli, P., Vestuto, V., & Moltedo, O. (2025) · Biomolecules · doi:10.3390/biom15070930 · Cited by 43
Sublethal engagement of apoptotic pathways in residual cancer
Killarney, S. T., Tait, S. W. G., Green, D. R., & Wood, K. C. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.07.005 · Cited by 42
Liao, H., Liu, S., Ma, Q., Huang, H., Goel, A., Torabian, P., Mohan, C. D., & Duan, C. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2024.119869 · Cited by 43
Exploiting Nanomaterial‐Mediated Autophagy for Cancer Therapy
Wei, W., Rosenkrans, Z. T., Luo, Q., Lan, X., & Cai, W. (2018) · Small Methods · doi:10.1002/smtd.201800365 · Cited by 42
Intracellular Transport in Cancer Metabolic Reprogramming
Sneeggen, M., Guadagno, N. A., & Progida, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.597608 · Cited by 42
Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma
Perez‐Neut, M., Haar, L., Rao, V. R., Santha, S., Lansu, K., Rana, B., Jones, W. K., & Gentile, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7831 · Cited by 42
Turriani, E., Lázaro, D. F., Ryazanov, S., Leonov, A., Giese, A., Schön, M., Schön, M. P., Griesinger, C., Outeiro, T. F., Arndt‐Jovin, D. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700200114 · Cited by 41
Antiglioma Potential of Coumarins Combined with Sorafenib
Sumorek-Wiadro, J., Zając, A., Langner, E., Skalicka‐Woźniak, K., Maciejczyk, A., Rzeski, W., & Jakubowicz-Gil, J. (2020) · Molecules · doi:10.3390/molecules25215192 · Cited by 42
Lebeaupin, C., Yong, J., & Kaufman, R. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40204-4_8 · Cited by 41
Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma
Demirsoy, Ş., Martín-Acebes, M. A., Maes, H., & Agostinis, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00240 · Cited by 39
Eigner, K., Filik, Y., Mark, F., Schütz, B., Klambauer, G., Moriggl, R., Hengstschläger, M., Stangl, H., Mikula, M., & Röhrl, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-17888-9 · Cited by 39
The future of targeted kinase inhibitors in melanoma
Caksa, S., Baqai, U., & Aplin, A. E. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108200 · Cited by 39
Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity
Yoo, Y.-S., Han, H. G., & Jeon, Y. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2969271 · Cited by 39
The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
Liu, X., Wu, J., Qin, H., & Xu, J. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0565-2 · Cited by 39
Oxidative Stress and Autophagy as Key Targets in Melanoma Cell Fate
Catalani, E., Giovarelli, M., Zecchini, S., Perrotta, C., & Cervia, D. (2021) · Cancers · doi:10.3390/cancers13225791 · Cited by 39
Paulitschke, V., Berger, W., Paulitschke, P., Hofstätter, E., Knapp, B., Dingelmaier‐Hovorka, R., Födinger, D., Jäger, W. R., Szekeres, T., Meshcheryakova, A., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0701 · Cited by 38
Wang, Y., Kaur, G., Chen, Y., Santos, A., Lošić, D., & Evdokiou, A. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07557 · Cited by 38
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
Smith, L. K., Rao, A. D., & McArthur, G. A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.009 · Cited by 38
ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells
Piao, S., Ojha, R., Rebecca, V. W., Samanta, A., Ma, X.-H., Mcafee, Q. W., Nicastri, M. C., Buckley, M. E., Brown, E. J., Winkler, J. D., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1377377 · Cited by 38
Self-citationmiR-216b enhances the efficacy of vemurafenib by targeting Beclin-1, UVRAG and ATG5 in melanoma
Luo, M., Wu, L., Zhang, K., Wang, H., Wu, S. K., O’Connell, D., Gao, T., Zhong, H., & Yang, Y. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.09.024 · Cited by 38
Gan, L., Liu, Z., Luo, D., Ren, Q., Wu, H., Li, C., & Sun, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01507 · Cited by 38
L’Hôte, V., Courbeyrette, R., Pinna, G., Cintrat, J., Le Pavec, G., Delaunay‐Moisan, A., Mann, C., & Thuret, J. (2021) · Aging Cell · doi:10.1111/acel.13447 · Cited by 37
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma
Ndoye, A., Budina-Kolomets, A., Kugel, C. H., Webster, M. R., Kaur, A., Behera, R., Rebecca, V. W., Li, L., Brafford, P. A., Liu, Q., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0907 · Cited by 37
Self-citationEndoplasmic reticulum stress in melanoma pathogenesis and resistance
Kong, Y., Jiang, J. L., Huang, Y., Li, L., Liu, X., Jin, Z., Wei, F., Liu, X., Zhang, S., Duan, X., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113741 · Cited by 37
Role of NADPH oxidase in the regulation of autophagy in cardiomyocytes
Sciarretta, S., Yee, D., Ammann, P. B., Nagarajan, N., Volpe, M., Frati, G., & Sadoshima, J. (2014) · Clinical Science · doi:10.1042/cs20140336 · Cited by 37
Conod, A., Silvano, M., & Altaba, A. R. I. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110490 · Cited by 37
New insights on the role of autophagy in the pathogenesis and treatment of melanoma
Rahmati, M., Ebrahim, S., Hashemi, S. B., Motamedi, M., & Moosavi, M. A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05886-6 · Cited by 37
Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma
Körholz, K. F., Ridinger, J., Krunic, D., Najafi, S., Gerloff, X. F., Frese, K., Meder, B., Peterziel, H., Vega-Rubín-de-Celis, S., Witt, O., et al. (2021) · Cells · doi:10.3390/cells10051001 · Cited by 36
Shen, X., Deng, Y., Chen, L., Liu, C., Li, L., & Huang, Y. (2023) · Advanced Science · doi:10.1002/advs.202301434 · Cited by 35
Maternal obesity alters endoplasmic reticulum homeostasis in offspring pancreas
Soeda, J., Mouralidarane, A., Cordero, P., Li, J., Nguyen, V., Carter, R. M., Kapur, S. R., Pombo, J., Poston, L., Taylor, P. D., et al. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0476-6 · Cited by 35
Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma
Saei, A., & Eichhorn, P. J. A. (2019) · Cancers · doi:10.3390/cancers11081176 · Cited by 35
The unfolded protein and integrated stress response in melanoma and vitiligo
Manga, P., & Choudhury, N. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12947 · Cited by 34
Autophagy Inhibition in BRAF-Driven Cancers
Foth, M., & McMahon, M. (2021) · Cancers · doi:10.3390/cancers13143498 · Cited by 34
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer
Delahaye, C., Figarol, S., Pradines, A., Favre, G., Mazières, J., & Calvayrac, O. (2022) · Cancers · doi:10.3390/cancers14112613 · Cited by 34
Hassan, M., Selimovic, D., Hannig, M., Haikel, Y., Brodell, R. T., & Megahed, M. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i4.206 · Cited by 33
Metadata
- Authors
- Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., Lazova, R., Klump, V., Pawelek, J. M., Xu, X., Xu, W., Schuchter, L. M., Davies, M. A., Herlyn, M., Winkler, J., Koumenis, C., & Amaravadi, R. K.
- Affiliations
- University of Pennsylvania (US)
- The Wistar Institute (US)
- Yale University (US)
- Abramson Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-02-24
- Volume
- 124
- Issue
- 3
- Pages
- 1406-1417
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3934165
- OpenAlex
- W2119735934
- Cited by
- 457
- References
- 52
- Citations by year
- 2026: 11 · 2025: 36 · 2024: 39 · 2023: 27 · 2022: 37 · 2021: 40 · 2020: 40 · 2019: 35 · 2018: 44 · 2017: 44 · 2016: 48 · 2015: 31 · 2014: 24
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Cancer Institute (P01CA114046, R01CA139362, K01CA175269, K23CA120862, R01CA169134, R01CA094214, P30CA016672, P30CA010815, P30CA016520)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- melanoma, BRAF inhibitor resistance, BRAF V600E mutation, endoplasmic reticulum stress, autophagy, cytoprotective autophagy, GRP78, PERK, MEK inhibition, autophagy inhibition, combination therapy, PI3K/mTOR signaling, progression-free survival
- MeSH terms
- Vemurafenib, Endoplasmic Reticulum Chaperone BiP, Animals, Antineoplastic Agents, Autophagy, Humans, Indoles, Melanoma, Mice, Nude, Sulfonamides, Drug Resistance, Neoplasm, Mutation, Missense, MAP Kinase Signaling System, Xenograft Model Antitumor Assays, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, Cell Proliferation, Mice, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.